Technical events and factor profile →
This 10-Q introduces no material changes to the risk factors vs. the latest annual report.
| Aug 26 | May 26 | Feb 26 | Nov 25 | Aug 25 | |
|---|---|---|---|---|---|
| Revenue | $3.0B | $2.9B | $2.8B | $2.8B | $2.7B |
| YoY growth | +10.9% | +8.9% | +8.9% | +9.3% | +8.7% |
| Gross margin | 51.5% | 51.0% | 51.0% | 50.4% | 50.3% |
| Operating margin | 23.6% | 23.2% | 23.2% | 23.4% | 22.7% |
| Net income | $552M | $511M | $502M | $495M | $491M |
| Diluted EPS | 1.36 | 1.26 | 1.24 | 1.21 | 1.20 |
XBRL data filed with the SEC. The fourth fiscal quarter is calculated as the full year minus the previous three quarters.
0 = the lowest in the universe, 100 = the highest. It describes how the stock has behaved, not whether to buy or sell it. Screen stocks by factors
Similar than in the previous 10-Q (2026-04-07: +20, -5 points)
10-Q of 2026-10-07 · 27.7% positive sentences, 13.9% negative · 166 sentences analysed
Index from −100 to +100 calculated with FinBERT on the results discussion (MD&A). The change matters more than the level: some sectors always sound more cautious.
| Bridgewater Associates · Ray Dalio
held since Q1 2026 |
0.0% | $5.5M | +182% |
Weight in each fund's portfolio and change vs. the previous quarter, from its latest 13F.
All material events for CTAS →
Source: SEC EDGAR. Automatic comparison of the risk factors section; it may contain extraction errors. Always check the original document. For information purposes only; not investment advice.